FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 呈交日期： 2025年12月19日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00314 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | ...

Group 1 - The article reports on share buybacks conducted by various companies on December 18, 2025, with Tencent Holdings leading in both the number of shares repurchased and the total amount spent [1] - Tencent Holdings repurchased 1.055 million shares for a total of 636 million yuan, representing 1.030% of its total share capital for the year [2] - Other notable companies involved in the buyback include Xiaomi Group, which repurchased 3.75 million shares for 151 million yuan, and China National Petroleum Corporation, which repurchased 254,000 shares for 116.38 million yuan [3] Group 2 - The total number of shares repurchased by companies varied significantly, with China National Petroleum Corporation having a cumulative buyback of 230 million shares, which is 0.190% of its total share capital [3] - Companies like IGG and VITASOY also participated, with IGG repurchasing 182,000 shares for 68.49 million yuan and VITASOY repurchasing 122,000 shares for 77.94 million yuan [3] - The buyback activity reflects a strategic move by these companies to enhance shareholder value and manage their capital structure effectively [1][2]

Group 1 - The core viewpoint of the news is that Sipai Health has been actively repurchasing its shares, indicating management's confidence in the company's stock value and financial health [1][2] - On December 18, Sipai Health repurchased 150,800 shares at an average price of 2.38 HKD per share, totaling approximately 359,500 HKD, bringing the total shares repurchased this year to 14,713,800, which accounts for 1.95% of the total share capital [1] - The recent share buyback is seen as a strategy to enhance earnings per share and improve capital structure, potentially positively influencing market sentiment [1] Group 2 - Sipai Health, established in 2014, focuses on healthcare services, including oncology management, pharmaceutical supply chain, and health insurance services [2] - The company integrates medical resources through a digital platform, providing comprehensive solutions for patients, doctors, and healthcare institutions [2] - Despite recent business expansion efforts, Sipai Health faces challenges in profitability and growth sustainability due to increased industry competition and regulatory environment [2]

Core Viewpoint - Sipai Health (00314) announced a share buyback plan, indicating a strategic move to enhance shareholder value through repurchasing shares at a price range of HKD 2.36 to 2.44 per share [1] Group 1 - The company will spend HKD 359,500 to repurchase 150,800 shares [1] - On the same day, the company issued 2,000 shares based on the revised and restated 2017 Global Share Option Plan [1]

智通财经APP讯，思派健康(00314)发布公告，于2025年12月18日，该公司斥资35.95万港元回购15.08万 股股份，每股回购价格为2.36-2.44港元。于同日，根据经修订及经重列2017年全球股份计划行使期权而 发行2000股股份。 ...

格隆汇12月18日丨思派健康(00314.HK)公告，12月18日耗资36万港元回购15万股。 ...

如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 00314 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | 每股發行/出售價 (註4) | | 已發行股份總數 | | | | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | | | | | 於下列日期開始時的結存(註1) ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 思派健康科技有限公司 呈交日期: 2025年12月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00314 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | USD | | 0.0001 | USD | | 200,000 | | 增加 / 減少 (-) | | | | | | | USD | | 0 | | 本月底結存 | | | 2,000,000,000 | USD | | 0.0001 | USD | | 200,000 | 本月底法定/註冊 ...

Core Viewpoint - Sipai Health (00314.HK) announced a share buyback of 263,000 shares at a cost of HKD 652,000 on November 5 [1] Summary by Category - **Company Actions** - The company executed a buyback of 263,000 shares, indicating a commitment to enhancing shareholder value [1] - The total expenditure for this buyback was HKD 652,000, reflecting the company's strategy to manage its capital effectively [1]

Core Viewpoint - Sipai Health (00314) announced a share buyback plan, indicating a strategic move to enhance shareholder value through the repurchase of shares [1] Group 1 - The company will spend approximately HKD 651,900 to repurchase 263,200 shares [1]